ACM
RXST icon

ADAR1 Capital Management’s RxSight RXST Stock Holding History

ADAR1 Capital Management’s Portfolio RXST Stock Details RXST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$266K Buy
43,250
+21,447
+98% +$178K 0.02% 247
2025
Q4 		$227K Buy
+21,803
New +$219K 0.02% 228

Other funds holding RXST

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
NSGL
No Street GP LP San Francisco, California $1.5B AUM 34.53% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

ADAR1 Capital Management's RXST Position: Q1 2026 in Review

ADAR1 Capital Management increased its RxSight (RXST) stake by 98% in Q1 2026, buying an estimated $178K and bringing the position to 43,250 shares worth $266K. The position accounts for 0.02% of the portfolio, ranked #247.

ADAR1 Capital Management first reported a position in RXST in Q4 2025 and has held it in 2 quarters since. 164 funds tracked by Wall St. Rank hold RXST as of Q1 2026.

  • ADAR1 Capital Management held 43,250 shares of RxSight worth $266K as of Q1 2026.
  • ADAR1 Capital Management bought 21,447 RxSight shares in Q1 2026, an estimated $178K.
  • RxSight made up 0.02% of ADAR1 Capital Management's portfolio in Q1 2026, its #247 holding.
  • ADAR1 Capital Management first reported a position in RxSight in Q4 2025 and has held it in 2 quarters since.
  • 164 funds tracked by Wall St. Rank held RxSight as of Q1 2026.

Based on ADAR1 Capital Management's 13F filing for Q1 2026, filed 18 May 2026.